
This Week’s Biopharma News: AstraZeneca Cans Phase III Trial
Credit: Adobestock.com The big business announcements: AstraZeneca axes phase III prostate cancer trial AstraZeneca is discontinuing a phase III trial of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) in …